Rainbow Children’s Medicare: Scaling Up for the Next Phase

plans to add approximately 2,500 beds over the next five years, doubling its total capacity to roughly 5,000 beds while management targets near-term revenue growth exceeding 20%. Robust Q1 FY27 Performance: Revenue grew 33% year-over-year to ₹470 crore with EBITDA rising 30% to ₹135 crore (28.6% margin). This operational momentum was driven by significant volume gains, including a 28% increase in inpatient discharges and a 25% rise in outpatient consultations. Temporary Margin Headwinds: EBITDA margins are expected to moderate to the 24–25% range for FY27 as newly commissioned facilities incur upfront fixed operating costs ahead of optimal capacity utilization. Shift to Capacity Monetisation: With major expansion cycles maturing, focus is transitioning from adding infrastructure to raising bed occupancy, creating operational leverage where incremental volumes boost EBITDA disproportionately. Strong Financial Foundations: Supported by ₹613 crore in cash and liquid reserves, Rainbow maintains a resilient balance sheet capable of funding future growth without compromising financial flexibility. Attractive Valuation & Industry Tailwinds: Positioned in the specialized pediatric and maternity care sector, Rainbow benefits from rising healthcare demand and currently trades at ~20x FY28e EV/EBITDA, representing a compelling entry point below historical averages.